Aug 21 (Reuters) - Lupin Ltd LUPN.NS : * LAUNCHES GENERIC CLOBETASOL PROPIONATE CREAM USP 0.05% IN US
Aug 21 (Reuters) - Lupin Ltd LUPN.NS : * GETS FDA APPROVAL FOR GENERIC HYDROCORTISONE BUTYRATE LOTION, 0.1% * HYDROCORTISONE BUTYRATE LOTION, 0.1% IS INDICATED FOR TOPICAL...
Lupin can move up faster than Sun Pharma from the current levels.
India’s benchmark Nifty saw fresh buying today even as it went on to make a new high of 11458 in the last hour of the day’s trade. The index has closed convincingly...
In the first hour of trade today, India’s benchmark Nifty opened at 11364, approximately 10 points above its previous close, signaling a continuation of a buying trend....
India’s benchmark Nifty, closed above its 4-day high at 10769 today. The index surprised most traders by registering a high of 10777 at a time when the world was worried...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Buy||Strong Buy||Buy||Buy||Sell|
|Technical Indicators||BUY||Strong Buy||Strong Buy||Strong Buy||Strong Sell|
|Summary||Buy||Strong Buy||Strong Buy||Strong Buy||Strong Sell|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Three Outside Up||5H||Current|
|Bullish Engulfing||5H||1||Aug 21, 2018 09:30|
|Falling Three Methods||1W||2||Aug 05, 2018|
|Doji Star Bearish||1H||2||Aug 21, 2018 13:30|
|Tata Steel Ltd||582.15||602.45||580.55||-17.25||-2.88%||10.87M||15:57:47|
Lupin Limited is a pharmaceutical company. The Company is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world. The Company offers products in the cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastro-intestinal, anti-infectives and non-steroidal anti-inflammatory drug therapy areas. The Company also offers solutions in the anti-tuberculosis (anti-TB) and cephalosporins therapy areas. The Company along with its subsidiaries has manufacturing locations spread across India, Japan, the United States, Mexico and Brazil. It has a pipeline of biosimilars addressing therapies, such as oncology, anti-inflammatory, anti-viral, rheumatoid arthritis, endocrinology, diabetes, ophthalmology and women's health. The Company's products include Antara, Methergine, Methylphenidate, Glumetza, Gluconorm, Tonact, Rcinex and Ramistar, among others.Read More
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.